-
Real-World Economic and Clinical Burden of Worsening Heart Failure in the US: Administrative Claims Database Analysis
Mar 10, 2025, 14:00 PM -
Matching-Adjusted Indirect Comparison of Isatuximab-Bortezomib-Lenalidomide-Dexamethasone (IVRd) with Daratumumab-Lenalidomide-Dexamethasone (DRd) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns
Mar 10, 2025, 14:00 PM -
Wider Societal Impact of Reducing Prevalence of Obesity: A Comparison of US and UK Impact Frameworks
Mar 10, 2025, 14:00 PM -
The Cost of Complications In Graft Repair For Extremity Arterial Trauma: Real-World Evidence From Linked Hospital Chargemaster And Insurance Claims Databases
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria
Mar 10, 2025, 14:00 PM -
Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?
Mar 10, 2025, 14:00 PM -
Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia
Mar 10, 2025, 14:00 PM -
Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
Comparison of Suicidal Ideation or Personal History of Self Harm Among Patients with Use of Rexulti and All Antipsychotics
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Prevalence of Mental Health Conditions Among Individuals With Sickle Cell Disease in Texas Medicaid
Mar 10, 2025, 14:00 PM -
Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec
Mar 10, 2025, 14:00 PM -
Trends in Antidiabetic Medication Use and Outpatient Pharmacy Costs in a Commercially Insured Diabetes Population from a US Payer Perspective
Mar 10, 2025, 14:00 PM -
Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data
Mar 10, 2025, 14:00 PM -
Cost-Savings of Primary Healthcare Nurse Practitioners' Planned Interventions for Reducing Transfers of Patients from Home Care to Emergency Departments in Quebec, Canada
Mar 10, 2025, 14:00 PM
